ArticleSmart molecules : open access2024
Dual-acceptor engineering of donor-acceptor type molecules for all-round boosting anti-tumor phototherapy.
Article in Smart molecules : open access, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Carbon Nanotube-Based Multi-Functional "Yin"-"Yang" Film: Dual Applications in Solar Water Evaporation and Blue Energy Harvesting.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Unveiling Photo-Thermal-Electrical Performance in Robust, Self-Healing, and Anti-Freezing Cellulose-MXene Eutectogels for Advanced Hemostasis.Nano-micro letters · 2026Article
- A lysosomal escape-enabled endoplasmic reticulum-targeting BODIPY photothermal agent for enhanced tumor ablation.Smart molecules : open access · 2026Article
- Molecular Descriptor of Electronic Transition for Regulating Polarity-Responsive Behavior of Heterocycle-Containing Probes.JACS Au · 2026Article
- Zero-trigger ultrafast charge-transfer J-aggregatesChemical science · 2026Article
- Donor Modulation of Strong Near-Infrared Lipid-Droplet Probes for in Vivo Diagnosis of Nonalcoholic Fatty Liver Disease.Chemical & biomedical imaging · 2026Article
- A recyclable type-I photosensitizer to enable red-light-driven gram-scale aerobic photocatalysis.Smart molecules : open access · 2025Article
- An azo substituted quinoline-malononitrile enzyme-activable aggregation-induced emission nanoprobe for hypoxia imaging.Smart molecules : open access · 2025Article
- Unveiling the Role of Alkyl Chain in Boosting Antibacterial Selectivity and Cell Biocompatibility.JACS Au · 2025Article
- A self-reinforced activatable photosensitizer prodrug enabling synergistic photodynamic and chemotherapy.Smart molecules : open access · 2024Article
- Cisplatin-coordinated copolythiophene for synergistic chemotherapy and sonodynamic therapy of tumor.Smart molecules : open access · 2024Article
- Dual-acceptor engineering of donor-acceptor type molecules for all-round boosting anti-tumor phototherapy.Smart molecules : open access · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The integration of robust photon-absorption capacity, high reactive oxygen species yields and photothermal conversion efficiency (PCE) into a single phototheranostic nano-agents is ideal but rarely reported. This study employed a dual-acceptor engineering strategy utilizing isoindigo and selenium-substituted [1,2,5]thiadiazolo[3,4-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.